As Peter Lynch said "buy companies that are hated by public"
Touched the bottom of downward channel. Upcoming PDUFA can affect the stock price in a negative way and push it to $1 (or even down below a bit).
The company has a huge debt and it is priced as BK company but it has great pipeline and it has all the chances to get a decent deal on opioid case. In such a case it will skyrocket. The issues are the same as they were when the stock price was $80. In case if opioid deal settled company capitalization will be 10 times higher at least. Drivers for further revenue growth: Terlipressin, Stratagraft, iNO. For now, valuation of the company is ridiculous.
Be aware it is very high risk game. Kind of binary game.
Touched the bottom of downward channel. Upcoming PDUFA can affect the stock price in a negative way and push it to $1 (or even down below a bit).
The company has a huge debt and it is priced as BK company but it has great pipeline and it has all the chances to get a decent deal on opioid case. In such a case it will skyrocket. The issues are the same as they were when the stock price was $80. In case if opioid deal settled company capitalization will be 10 times higher at least. Drivers for further revenue growth: Terlipressin, Stratagraft, iNO. For now, valuation of the company is ridiculous.
Be aware it is very high risk game. Kind of binary game.